1. Dominguez LJ, Barbagallo M, Morley JE. Anti-aging medicine: pitfalls and hopes. Aging Male. 2009;12:13-20.
2. Vaillant GE. Aging Well. Surprising Guidepost to a Happier Life From the Landmark Harvard Study of Adult Development. New York: Little, Brown and Co; 2002:373.
3. Fredrickson BL. The role of positive emotions in positive psychology. The broaden-and-build theory of positive emotions. Am Psychol. 2001;56:218-226.
4. Fredrickson BL, Joiner T. Positive emotions trigger upward spirals toward emotional well-being. Psychol Sci. 2002;13:172-175.
5. Rowe JW, Kahn RL. Successful Aging. New York: Dell Publishing; 1999:265.
6. Depp CA, Jeste DV. Definitions and predictors of successful aging: a comprehensive review of larger quantitative studies. Am J Geriatr Psychiatry. 2006;14:6-20.
7. Peel NM, McClure RJ, Bartlett HP. Behavioral determinants of healthy aging. Am J Prev Med. 2005;28:298-304.
8. Selye H. The Stress of Life. New York: McGraw-Hill; 1956.
9. McEwen BS. The End of Stress as We Know It. Washington, DC: National Academies Press; 2004:239.
10. Miller MM, McEwen BS. Establishing an agenda for translational research on PTSD. Ann N Y Acad Sci. 2006;1071:294-312.
11. Sterling P, Eyer J. Allostasis: a new paradigm to explain arousal pathology. In: Fisher S, Reason J, eds. Handbook of Life Stress, Cognition, and Health. New York: John Wiley & Sons; 1988:629-649.
12. McEwen BS. Sex, stress, and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol Aging. 2002;23:921-939.
13. Seeman TE, McEwen BS, Rowe JW, Singer BH. Allostatic load as a marker of cumulative biological risk: McArthur studies of successful aging. Proc Natl Acad Sci U S A. 2001;98:4770-4775.
14. Karlamangla AS, Singer BH, McEwen BS, et al. Allostatic load as a predictor of functional decline. MacArthur studies of successful aging. J Clin Epidemiol. 2002;55:696-710.
15. Black S, Humphrey JH, Niven JS. Inhibition of the Mantoux reaction by direct suggestion under hypnosis. Br Med J. 1963;1:1649-1652.
16. Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc. 1993;41:176-181.
17. Ferrucci L, Harris TB, Guralnik JM, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc. 1999;47:639-646.
18. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, et al. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci U S A. 2003;100:9090-9095.
19. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol. 2004;39:687-699.
20. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 1998;128:127-137.
21. Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106:506-512.
22. Davidson RJ. Affective style, psychopathology, and resilience: brain mechanisms and plasticity. Am Psychol. 2000;55:1196-1214.
23. Davidson RJ. Anxiety and affective style: role of prefrontal cortex and amygdala. Biol Psychiatry. 2002;51:68-80.
24. Lavretsky H, Irwin MR. Resilience and aging. Aging Health. 2007;3:309-323.
25. Werner EE. The children of Kaui: resiliency and recovery in adolescence and adulthood. J Adolesc Health. 1992;13:262-268.
26. Ryff CD, Singer BH, Dienberg Love G. Positive health: connecting well-being with biology. Philos Trans R Soc Lond B Biol Sci. 2004;359:1383-1394.
27. Richardson GE, Waite PJ. Mental health promotion through resilience and resiliency education. Int J Emerg Ment Health. 2002;4:65-75.
28. Fava GA, Rafanelli C, Cazzaro M, et al. Well-being therapy. A novel psychotherapeutic approach for residual symptoms of affective disorders. Psychol Med. 1998;28:475-480.
29. Fava GA, Ruini C, Rafanelli C, et al. Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry. 2004;161:1872-1876.
30. Fava GA, Ruini C, Rafanelli C, et al. Well-being therapy of generalized anxiety disorder. Psychother Psychosom. 2005;74:26-30.
31. Ruini C, Belaise C, Brombin C, et al. Well-being therapy in school settings: a pilot study. Psychother Psychosom. 2006;75:331-336.
32. Ryff CD, Singer BH. Flourishing under fire: resilience as a prototype of challenged thriving. In: Keyes CL, Haidt J, eds. Flourishing: Positive Psychology and the Life Well-Lived. Washington, DC: American Psychological Association; 2003:15-36.
33. Fava GA. Well-being therapy: conceptual and technical issues. Psychother Psychosom. 1999;68:171-179.
34. Miller GE, Cohen S. Psychological interventions and the immune system: a meta-analytic review and critique. Health Psychol. 2001;20:47-63.
35. Irwin M, Pike J, Oxman M. Shingles immunity and health functioning in the elderly: tai chi chih as a behavioral treatment. Evid Based Complement Alternat Med. 2004;1:223-232.
36. Irwin MR, Olmstead R, Oxman MN. Augmenting immune responses to varicella zoster virus in older adults: a randomized, controlled trial of Tai Chi. J Am Geriatr Soc. 2007;55:511-517.
37. Motivala SJ, Sollers J, Thayer J, Irwin MR. Tai chi chih acutely decreases sympathetic nervous system activity in older adults. J Gerontol A Biol Sci Med Sci. 2006;61:1177-1180.
38. Lutgendorf SK, Antoni MH, Kumar M, Schneiderman N. Changes in cognitive coping strategies predict EBV-antibody titre change following a stress-or disclosure induction. J Psychosom Res. 1994;38:63-78.
39. Segerstrom SC, Taylor SE, Kemeny ME, Fahey JL. Optimism is associated with mood, coping, and immune change in response to stress. J Pers Soc Psychol. 1998;74:1646-1655.
40. Phillips AC, Burns VE, Lord JM. Stress and exercise: getting the balance right for aging immunity. Exerc Sport Sci Rev. 2007;35:35-39.
41. Epel E, Daubenmier J, Moskowitz JT, et al. Can meditation slow rate of cellular aging? Cognitive stress, mindfulness, and telomeres. Ann N Y Acad Sci. 2009;1172:34-53.
42. Lavretsky H, Siddarth P, Irwin MR. Improving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram. Am J Geriatr Psychiatry. 2010;18:154-162.
43. Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999;175:17-22.
44. Davidson JR, Stein DJ, Rothbaum BO, et al. Resilience as a predictor of remission in PTSD patients treated with venlafaxine XR or placebo. Poster presented at: Annual Meeting of the Anxiety Disorders of America; March 23-26, 2006; Miami.